my 1250 has been researched along with calcimycin in 1 studies
| Studies (my 1250) | Trials (my 1250) | Recent Studies (post-2010) (my 1250) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 13 | 1 | 0 | 11,946 | 40 | 444 |
| Protein | Taxonomy | my 1250 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadowaki, S; Takahashi, K; Umezu, K; Yamada, N | 1 |
1 other study(ies) available for my 1250 and calcimycin
| Article | Year |
|---|---|
MY-1250, a major metabolite of the anti-allergic drug repirinast, induces phosphorylation of a 78-kDa protein in rat mast cells.
Topics: Animals; Calcimycin; Drug Interactions; Histamine Antagonists; Histamine H1 Antagonists; Male; Mast Cells; Phosphorylation; Proteins; Quinolones; Rats; Rats, Wistar | 1992 |